It's not just about surviving the first wave. Let's hope MSB can do that and yes it is obviously the first consideration. What about recovery
https://www.eatthis.com/fauci-post-covid-syndrome/
Heart, kidney, nerve and neurologic disorders unfortunately not in small numbers either. Hope that these people don't get reinfected in the advent of a second wave.
Now would anyone know of a single company that has done a massive amount of work on the above? MSB
Remestemcell L has been described as a therapy of last resort. Why? Other drugs appear to be cheap however do they address the long term medical conditions of those that do survive. Our P2/3 trial could provide the answers.
Should the P2/3 trial be stopped before this is definitely answered even though the results may be outstanding? NO
It would be a massive mistake to presume that our treatment would only be used as a last resort leaving those that do survive a life of ill health and huge economic cost to the community. It may be far more benefit to use our therapy first and only use the others as a last resort.
Good luck and stay safe.
- Forums
- ASX - By Stock
- MSB
- Cell Therapy News/Articles
Cell Therapy News/Articles, page-4583
-
- There are more pages in this discussion • 13,447 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add MSB (ASX) to my watchlist
|
|||||
Last
$1.07 |
Change
0.005(0.47%) |
Mkt cap ! $1.216B |
Open | High | Low | Value | Volume |
$1.08 | $1.10 | $1.06 | $3.371M | 3.135M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
8 | 45345 | $1.06 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$1.07 | 3875 | 2 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
8 | 45345 | 1.055 |
9 | 193430 | 1.050 |
3 | 44331 | 1.045 |
5 | 117942 | 1.040 |
3 | 53830 | 1.035 |
Price($) | Vol. | No. |
---|---|---|
1.065 | 3875 | 2 |
1.070 | 28953 | 3 |
1.075 | 46564 | 3 |
1.080 | 87551 | 5 |
1.085 | 47614 | 4 |
Last trade - 16.10pm 03/09/2024 (20 minute delay) ? |
Featured News
MSB (ASX) Chart |